Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin | Zendy

Carolyn Watson | Zendy; J. Watt-Watson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin

Author(s) -

Carolyn Watson,

J. Watt-Watson

Publication year - 1999

Publication title -

pain research and management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.702

H-Index - 56

eISSN - 1918-1523

pISSN - 1203-6765

DOI - 10.1155/1999/961273

Subject(s) - gabapentin , neuropathic pain , medicine , postherpetic neuralgia , amitriptyline , pregabalin , randomized controlled trial , anticonvulsant , neuralgia , anesthesia , intensive care medicine , psychiatry , alternative medicine , epilepsy , pathology

BACKGROUND: The treatment of neuropathic pain continues to be difficult. Randomized, controlled trials (RCTs) provide some evidence to guide therapy. Most data relate to antidepressant therapy, although there is information on anticonvulsants and other treatments. Mistaken beliefs about many of these treatments are prevalent and need to be dispelled. Opioids are increasingly being used for the refractory patient. There has been recent enthusiasm for the anticonvulsant gabapentin for the treatment of these conditions

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research